The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
April 15th 2025
A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.
This Week in Managed Care: February 20, 2016
February 20th 2016This week's top managed care stories included the release of 7 core sets of quality measures, more evidence that value-based insurance design works to lower costs, and the FDA assigns breakthrough designation to AstraZeneca's PD-L1 inhibitor.
Watch
Continuity of Care and Changes in Medication Adherence Among Patients With Newly Diagnosed Diabetes
February 16th 2016This study identified 4 distinct medication adherence trajectories and found that continuity of care was consistently associated with medication adherence in every trajectory group.
Read More
Data Show Diabetics Using Verapamil Have Lower Glucose Levels
February 12th 2016The results amplify earlier work at UAB that showed verapamil reversed type 1 diabetes in mice. A clinical trial involving the drug in recently diagnosed patients with type 1 disease is still enrolling participants.
Read More
Life-Saving Insulin Too Costly for Many of the World's Type 1 Diabetics, Lancet Review Finds
February 6th 2016The authors note that not only are insulin costs making type 1 diabetes deadly in the poorest nations; high costs are the leading reason for diabetic ketoacidosis in the inner cities in the United States.
Read More
This Week in Managed Care: February 6, 2016
February 6th 2016The top stories in managed care this week included increased insurer concerns over the sustainability of the Affordable Care Act's insurance exchanges, healthy policy experts convened in DC, and 2 warnings for women to heed regarding pregnancy.
Read More